Towards the end of last year NICE published new guidelines on the treatment of Type 2 diabetes. As part of these, they recommended further restrictions on Self-Testing of Blood Glucose people with Type 2 Diabetes (PWD). This advice is based on the very reasonable argument that the overall effect of self-monitoring is small, but this argument stands in stark contrast to my personal experience, and to the experience of a great many others... it seems that taking a closer look at the science behind the argument is worthwhile.

December 2015 saw The National Institute for Health and Care Excellence publish new guidelines on the treatment of Type 2 diabetes. Although not mandatory, this document will have a profound impact on the way people with type 2 diabetes like myself receive treatment.